コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 conducted, which included a mammogram and a Papanicolaou test.
2 the number of previous consecutive negative Papanicolaou tests.
3 mmography, 14.7% [95% CI, 13.7%-15.6%] had a Papanicolaou test, 23.3% [95% CI, 22.6%-24.0%] had a PSA
4 .001), mammography (69.4% vs 75.1%; P<.001), Papanicolaou tests (69.2% vs 77.1%; P<.001), and psychia
5 of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations i
6 gative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations wou
7 u tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that wou
8 ds to increased rates of abnormal results of Papanicolaou tests and contributes to the increased rate
9 Medical record documentation of mammography, Papanicolaou testing, and colorectal cancer screening ac
10 tible health plan fully covered mammography, Papanicolaou tests, and fecal occult blood testing (FOBT
11 -based cytology and computerized analysis of Papanicolaou tests are examples of attempts at this appr
12 ithin three years after one or more negative Papanicolaou tests, as well as the number of additional
13 uidelines suggest that the intervals between Papanicolaou tests can be extended to three years among
14 mammography (95% CI, 0.06 to 0.19), 0.07 for Papanicolaou testing (CI, 0.01 to 0.12), and 0.13 for co
15 onusers, independent of sexual behavior, and Papanicolaou test diagnosis (AHR: 0.67 [95% CI: .49-.93]
16 the order in which they were performed (eg, Papanicolaou test followed by human papillomavirus [HPV]
17 nt, and the positive predictive value of the Papanicolaou test for detecting vaginal cancer was 0 per
18 el, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 amon
19 0.58 with usual care; the proportion who had Papanicolaou testing increased from 0.71 to 0.78 with th
20 squamous cells (ASC) depends on whether the Papanicolaou test is subcategorized as of undetermined s
21 have had three or more consecutive negative Papanicolaou tests is associated with an average excess
24 of cancer screening procedures (mammography, Papanicolaou test, prostate-specific antigen [PSA], and
25 ual behavior, genital tract coinfection, and Papanicolaou test results were assessed at baseline and
26 , 8.6%-9.1%) vs 22.0% (95% CI, 21.7%-22.5%); Papanicolaou test screening was received by 5.8% (95% CI
29 vulvovaginal samples for HPV DNA testing and Papanicolaou testing were collected at gynecologic exami
30 squamous cells of undetermined significance Papanicolaou test with satisfactory results for all 4 HP
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。